SUBSCRIBE
SUBSCRIBE
News   Business

DOR BioPharma, Inc. Reports Second Quarter 2006 Financial Results And Reviews Achievements

August 15, 2006 | 
1 min read

DOR BioPharma, Inc. (OTCBB:DORB) (“DOR” or the “Company”), announced today its financial results for the second quarter ended June 30, 2006.

Earnings
MORE ON THIS TOPIC
closeup hot glue gun with melted glue dripping out
Deals
AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B
January 23, 2025
 · 
1 min read
 · 
Annalee Armstrong
Biogen’s headquarters in Massachusetts
Layoffs
Biogen Trims Research Workforce, Higher-Dose SMA Drug Accepted for Regulatory Review
January 23, 2025
 · 
3 min read
 · 
Tristan Manalac
Concept of money prize. Vector illustration. Halftone hand holds bouquet of money flowers. Gift prize, donation, earnings, bonus or cashback concept. Retro poster or banner. Creative trend collage.
Manufacturing
Samsung Biologics Continues Mega-Deal Streak With $1.4B European Contract
January 23, 2025
 · 
2 min read
 · 
Tristan Manalac
Oct 9, 2019 Milpitas / CA / USA - Johnson & Johnson Vision offices in Silicon Valley; Johnson & Johnson Vision Care, Inc. is part of the American multinational corporation Johnson&Johnson
Earnings
J&J Says Deals Likely to Shrink After $14.6B Intra-Cellular Buy
January 22, 2025
 · 
3 min read
 · 
Annalee Armstrong